COVID-19 Vaccine Manufacturers Urged To Make Labeling Changes To Avoid Administration Errors
CDC advisory panel members voice concerns about mix-ups in the administration of COVID-19 vaccines. Pfizer’s bivalent and monovalent vaccines have the same gray cap while Moderna has different colored caps for its two versions.
You may also be interested in...
But agency assessors also said there did not appear to be a biological reason for the vaccine to cause depression when granting the emergency use authorization for use of the Novavax vaccine in 12- to 17-year-olds.
One member says the vote was premature, but others conclude extrapolation of clinical data from another vaccine was sufficient given similar experience with flu vaccines and the potential to save thousands of lives.
Unlike with traditional approvals, emergency use authorization requires medication error reports to be submitted to the FDA, offering additional insight into why they occur.